Securian Asset Management, Inc Roivant Sciences Ltd. Transaction History
Securian Asset Management, Inc
- $3.4 Billion
- Q2 2024
A detailed history of Securian Asset Management, Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Securian Asset Management, Inc holds 26,994 shares of ROIV stock, worth $319,608. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,994
Previous 27,820
2.97%
Holding current value
$319,608
Previous $293,000
2.73%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
312Shares Held
496MCall Options Held
991KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$845 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$819 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$790 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$419 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$347 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.34B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...